enzalutamide

protein tyrosine phosphatase receptor type F ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32042320 Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts. 2020 1
2 27255535 Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer. 2016 Jun 1